Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - PFIZER INC.

30 Oct 2015 15:48

RNS Number : 0911E
FIL Limited
30 October 2015
Β 

ο»Ώ

Β 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2007 (AS AMENDED)

Β 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIESREPRESENTING 1% OR MORE

Β 

1. KEY INFORMATION

Β 

Name of person dealing (Note 1)

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

Β 

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

29-October-15

Β 

2. INTERESTS AND SHORT POSITIONS

Β 

(a) Interests and short positions (following dealing) in the class of relevant securitydealt in (Note 3)

Β 

Β 

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

56,288,533 0.91%

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Β 

1,560,000 0.02%

Total

Β 

56,288,533 0.91%

1,560,000 0.02%

Β 

Please note that the above positions include a transfer in for 375 shares.

Β 

(b) Interests and short positions in relevant securities of the company, other than theclass dealt in (Note 3)

Β 

Class of relevant security:

Β 

Long

Short

Β 

Β 

Number (%)

Number (%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Total

Β 

Β 

3. DEALINGS (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/sale

Β 

Number of securities

Price per unit

Buy

308

34.6784 USD/ Share

Buy

143,300

35.1 USD/ Share

Buy

1,060

35.45 USD/ Share

Buy

5,111

35.56 USD/ Share

Buy

28

35.31 USD/ Share

Buy

59

35.57 USD/ Share

Buy

104

35.41 USD/ Share

Buy

1,101

35.4465 USD/ Share

Buy

20

35.5669 USD/ Share

Buy

85

35.556 USD/ Share

Sale

820

35.45 USD/ Share

Sale

122

35.445 USD/ Share

Sale

8

35.515 USD/ Share

Sale

243

35.4466 USD/ Share

Sale

269

35.55 USD/ Share

Sale

71

33.9732 USD/ Share

Sale

2

35.51 USD/ Share

Sale

62

35.29 USD/ Share

Sale

9

35.52 USD/ Share

Sale

18

35.5466 USD/ Share

Sale

14

35.40 USD/ Share

Sale

1

35.44 USD/ Share

Sale

21

34.545 USD/ Share

Sale

1

33.90 USD/ Share

Β 

(b) Derivatives transactions (other than options transactions)

Β 

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

Β 

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product name,

e.g. call option

Β 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

Β 

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Β 

Nature of transaction (Note 8)

Β 

Details

Price per unit (if applicable) (Note 5)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Is a Supplemental Form 8 attached? (Note 9) Yes

Β 

Β 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

Β 

OPEN POSITIONS (Note 1)

Β 

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Call Option

Written

Β 5,000

37.00 USD

American

20 Nov 2015

Call Option

Written

Β 22,000

38.00 USD

American

20 Nov 2015

Call Option

Written

Β 17,500

36.00 USD

American

15 Jan 2016

Call Option

Written

Β 20,000

37.00 USD

American

15 Jan 2016

Call Option

Written

Β 2,500

35.00 USD

American

18 Dec 2015

Call Option

Written

Β 7,500

36.00 USD

American

20 Nov 2015

Call Option

Written

Β 35,000

36.00 USD

American

18 Dec 2015

Call Option

Written

Β 2,500

37.00 USD

American

19 Feb 2016

Call Option

Written

1,448,000

35.00 USD

American

20 Nov 2015

Β 

Β 

Date of disclosure

30-October-15

Contact name

Sally-Ann Hatton

Telephone number

01737 837148

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEFDMFISFISELS
Date   Source Headline
7th May 201411:20 amBUSForm 8.3 - Pfizer Inc
7th May 201410:40 amRNSForm 8.5 (EPT/RI) astrazeneca PLC
7th May 201410:38 amRNSForm 8.5 (EPT/RI) Astrazeneca PLC
7th May 201410:36 amRNSForm 8.5 (EPT/RI) Pfizer INC
7th May 201410:31 amRNSRule 2.10 Announcement
7th May 201410:30 amRNSForm 8.5 (EPT/RI) Astrazeneca PLC
7th May 201410:29 amRNSForm 8.5 (EPT/RI) Pfizer Inc
7th May 20147:00 amRNSBENEFITS OF A COMBINATION WITH ASTRAZENECA
7th May 20147:00 amRNSForm 8.5 (EPT/NON-RI)
6th May 20146:16 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
6th May 20146:08 pmRNSForm 8.5 (EPT/NON-RI)(OPD)
6th May 20145:15 pmRNSForm 8 (DD) - Pfizer Inc.
6th May 20144:46 pmRNSForm 8.3 - Pfizer Inc
6th May 20144:42 pmRNSForm 8.3 - Pfizer Inc
6th May 20144:16 pmRNSForm 8.5 (EPT/RI)replacement - Pfizer Inc
6th May 20144:14 pmRNSForm 8.5 (EPT/RI) Replacement - Pfizer Inc
6th May 20144:11 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer Inc
6th May 20144:07 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer Inc
6th May 20144:05 pmRNSForm 8.5 (EPT/RI) Replacement - Pfizer Inc
6th May 20144:04 pmRNSForm 8.5 (EPT/RI)replacement - Pfizer Inc
6th May 20144:02 pmBUSForm 8.3 - PFIZER INC
6th May 20143:56 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:53 pmRNSForm 8.5 (EPT/RI) Replacement - Astrazeneca PLC
6th May 20143:51 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:51 pmRNSForm 8.5 (EPT/RI)Replacement - Astrazeneca PLC
6th May 20143:49 pmRNSForm 8.5 (EPT/RI) Replacement - Astrazeneca PLC
6th May 20143:46 pmRNSForm 8.5 (EPT/RI)replacement - Astrazeneca PLC
6th May 20143:34 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:23 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:19 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:19 pmRNSForm 8.3 - Pfizer Inc
6th May 20143:18 pmRNSForm 8.3 - astrazeneca plc
6th May 20143:16 pmRNSForm 8.3 - PFIZER INC
6th May 20143:15 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20143:14 pmBUSForm 8.3 - Pfizer Inc.
6th May 20143:00 pmRNSForm 8.3 - Pfizer Inc.
6th May 20142:51 pmRNSForm 8.3 - [PFIZER INC]
6th May 20142:48 pmBUSForm 8.3 - Pfizer Inc
6th May 20142:31 pmRNSForm 8.3 - [Pfizer/Astrazeneca]
6th May 20141:54 pmRNSForm 8.3 - Pfizer Inc
6th May 20141:48 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20141:28 pmRNSForm 8.3 - Pfizer Inc
6th May 20141:25 pmRNSForm 8.3 - AstraZeneca Plc
6th May 20141:20 pmRNSForm 8.3 - [AstraZeneca Plc]
6th May 20141:14 pmBUSForm 8.3 - Pfizer Inc.
6th May 20141:13 pmRNSForm 8.5 (EPT/RI)
6th May 20141:09 pmRNSForm 8.5 (EPT/NON-RI)
6th May 20141:07 pmBUSForm 8.3 - Pfizer Inc.
6th May 20141:06 pmRNSForm 8.5 (EPT/RI)
6th May 201412:35 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.